JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ACAD Financials - Acadia Pharmaceuticals Income & Cash Flow | Ledgeburg
ACAD - Acadia Pharmaceuticals Inc.
USD | NASDAQ | Healthcare
Summary
Summary ACAD Stock
Financials
Financials ACAD Stock
Loading...
Loading...
Income Statement
Income Statement ACAD Stock
Balance Sheet
Balance Sheet ACAD Stock
Cash Flow Statement
Cash Flow Statement ACAD Stock
Loading...
Loading...
Home
Stocks
Acadia Pharmaceuticals Inc. (ACAD)
Financials
Financials of ACAD
Loading...
Loading...
Loading...
Loading...
Revenue
$1.071505B
Operating Income
$104.811M
Net Income
$391M
Share Count (Basic)
168.356M
Operating Cash Flow
$109.836M
Free Cash Flow
$105.146M
Cash And Short-Term Equivalents
$177.695M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
800M
1B
FY2021
FY2022
FY2023
Revenue $USD
0
100M
200M
300M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-200M
0
200M
400M
Annual
Quarterly
Margins
Gross
Operating
Net
-50%
0%
50%
100%
FY2024
FY2025
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
0
50M
100M
150M
200M
250M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26